NCT00086359View on ClinicalTrials.gov

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

September 30, 2007

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate, lamivudine, and zidovudine

one pill twice daily

DRUG

Lamivudine/zidovudine

one pill twice daily

DRUG

Lopinavir/ritonavir

four pills twice daily

Trial Locations (8)

10457

Bronx-Lebanon CRS, The Bronx

33136

Univ. of Miami Ped. Perinatal HIV/AIDS CRS, Miami

60608

Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program, Chicago

77030

Texas Children's Hosp. CRS, Houston

90033

Usc La Nichd Crs, Los Angeles

92103

UCSD Mother-Child-Adolescent Program CRS, San Diego

38105-2794

Regional Med. Ctr. at Memphis, Memphis

Unknown

San Juan City Hosp. PR NICHD CRS, San Juan

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00086359 - Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV | Biotech Hunter | Biotech Hunter